Stay updated on Nemtabrutinib in Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the Nemtabrutinib in Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nemtabrutinib in Hematologic Malignancies Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.3.2, replacing Revision: v3.3.1. No content or study data changes are included.
    Difference
    0.0%
    Check dated 2025-12-01T16:57:55.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The Publications section now clarifies that entries are provided voluntarily by the data submitter and may be auto-filled from PubMed. The revision note records v3.3.1, replacing the previous v3.2.0 wording.
    Difference
    0.1%
    Check dated 2025-11-24T13:36:02.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The site-wide notice about potential delays due to a lapse in government funding at the top of the ClinicalTrials.gov page was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T06:34:18.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The update appears to be minor UI adjustments and an updated timestamp, with core study details, eligibility criteria, dosing, endpoints, and locations unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T01:12:54.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    - Added a funding/status notice and updated to v3.2.0. - Removed the term ‘Richter syndrome’ and old version reference v3.1.0.
    Difference
    2%
    Check dated 2025-10-05T10:00:19.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Core terminology updated: 'Diffuse large B-cell lymphoma' is replaced with 'Malignant lymphoma, large B-cell, diffuse' and the page version advances from v3.0.2 to v3.1.0.
    Difference
    0.5%
    Check dated 2025-09-28T03:11:01.000Z thumbnail image

Stay in the know with updates to Nemtabrutinib in Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nemtabrutinib in Hematologic Malignancies Clinical Trial page.